» Articles » PMID: 17499326

Recombinant Modified Vaccinia Virus Ankara Provides Durable Protection Against Disease Caused by an Immunodeficiency Virus As Well As Long-term Immunity to an Orthopoxvirus in a Non-human Primate

Overview
Journal Virology
Specialty Microbiology
Date 2007 May 15
PMID 17499326
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Recombinant and non-recombinant modified vaccinia virus Ankara (MVA) strains are currently in clinical trials as human immunodeficiency virus-1 (HIV) and attenuated smallpox vaccines, respectively. Here we tested the ability of a recombinant MVA delivered by alternative needle-free routes (intramuscular, intradermal, or into the palatine tonsil) to protect against immunodeficiency and orthopoxvirus diseases in a non-human primate model. Rhesus macaques were immunized twice 1 month apart with MVA expressing 5 genes from a pathogenic simian human immunodeficiency virus (SHIV)/89.6P and challenged intrarectally 9 months later with the pathogenic SHIV/89.6P and intravenously 2.7 years later with monkeypox virus. Irrespective of the route of vaccine delivery, binding and neutralizing antibodies and CD8 responses to SHIV and orthopoxvirus proteins were induced and the monkeys were successively protected against the diseases caused by the challenge viruses in unimmunized controls as determined by viral loads and clinical signs. These non-human primate studies support the clinical testing of recombinant MVA as an HIV vaccine and further demonstrate that MVA can provide long-term poxvirus immunity, essential for use as an alternative smallpox vaccine.

Citing Articles

Short-Lived Neutralizing Antibody Responses to Monkeypox Virus in Smallpox Vaccine-Naive Persons after JYNNEOS Vaccination.

Phipps K, Yates J, Pettit J, Bialosuknia S, Hunt D, Dupuis 2nd A Emerg Infect Dis. 2025; 31(2):237-245.

PMID: 39793541 PMC: 11845161. DOI: 10.3201/eid3102.241300.


Advancements in monkeypox vaccines development: a critical review of emerging technologies.

Garcia-Atutxa I, Mondragon-Teran P, Huerta-Saquero A, Villanueva-Flores F Front Immunol. 2024; 15:1456060.

PMID: 39464881 PMC: 11502315. DOI: 10.3389/fimmu.2024.1456060.


T Cell Responses against Orthopoxviruses in HIV-Positive Patients.

Stefanie S, Koldehoff M, Schenk-Westkamp P, Horn P, Esser S, Lindemann M Vaccines (Basel). 2024; 12(2).

PMID: 38400115 PMC: 10891540. DOI: 10.3390/vaccines12020131.


Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus.

Chiuppesi F, Zaia J, Gutierrez-Franco M, Ortega-Francisco S, Ly M, Kha M Commun Med (Lond). 2024; 4(1):19.

PMID: 38366141 PMC: 10873322. DOI: 10.1038/s43856-024-00443-9.


Animal models of mpox virus infection and disease.

Wei Z, Zhao Y, Wang Z, Sui L, Zhao Y, Liu Q Infect Med (Beijing). 2023; 2(3):153-166.

PMID: 38073883 PMC: 10699680. DOI: 10.1016/j.imj.2023.05.004.


References
1.
Hu S . Non-human primate models for AIDS vaccine research. Curr Drug Targets Infect Disord. 2005; 5(2):193-201. PMC: 1488817. DOI: 10.2174/1568005054201508. View

2.
Enserink M . Bioterrorism. In search of a kinder, gentler vaccine. Science. 2002; 296(5573):1594. DOI: 10.1126/science.296.5573.1594. View

3.
Cline A, Bess J, Piatak Jr M, Lifson J . Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS. J Med Primatol. 2005; 34(5-6):303-12. DOI: 10.1111/j.1600-0684.2005.00128.x. View

4.
Aldaz-Carroll L, Whitbeck J, Ponce de Leon M, Lou H, Pannell L, Lebowitz J . Physical and immunological characterization of a recombinant secreted form of the membrane protein encoded by the vaccinia virus L1R gene. Virology. 2005; 341(1):59-71. DOI: 10.1016/j.virol.2005.07.006. View

5.
Rao S, Gomez P, Mascola J, Dang V, Krivulka G, Yu F . Comparative evaluation of three different intramuscular delivery methods for DNA immunization in a nonhuman primate animal model. Vaccine. 2005; 24(3):367-73. DOI: 10.1016/j.vaccine.2005.07.072. View